Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
- Everest Medicines appointed Lakshmi Srinivasan, PhD, as Senior Vice President and Brandon Coder, PhD, as Vice President.
- The appointments are intended to strengthen Everest Medicines’ global research and development capabilities in mRNA therapeutics.
- Srinivasan and Coder will lead clinical development of Everest Medicines’ mRNA programs and help expand its United States presence while working with the company’s China research team.
31 Articles
31 Articles
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead, Cancer Vaccines at Moderna, join Everest MedicinesAppointments support continued advancement of Everest's mRNA pipeline, including a…
Everest Medicines appoints ex-Moderna scientists to lead mRNA platform
Hong Kong, October 9, 2026: Everest Medicines (1952.HK) has named Lakshmi Srinivasan, PhD, as Senior Vice President, Head of Translational Medicine, and Brandon Coder, PhD, as Vice President, Translational Sciences & Discovery, both of whom previously held leadership roles in mRNA cancer vaccine research at Moderna. The appointments are intended to bolster Everest Medicines’ global […]
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




















